サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439342

眼科用粘弾性デバイス（OVD）- 世界市場の考察、競合情勢、市場予測（2030年）

Ophthalmic Viscoelastic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
眼科用粘弾性デバイス（OVD）- 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の眼科用粘弾性デバイス（OVD）の市場規模は、2023年に25億米ドル、2030年までに32億1,000万米ドルに達し、2024年～2030年の予測期間にCAGRで4.23％の成長が見込まれます。市場は、白内障、緑内障などの眼科疾患の有病率の上昇、技術の進歩、老年人口の急増などにより成長が見込まれています。

眼科用粘弾性デバイス（OVD）の市場力学

眼科用粘弾性デバイス（OVD）市場は、長年にわたって眼内の繊細な構造を保護するために眼内手術で使用されてきたという事実により、大きく拡大しています。これらのデバイスの使用は、白内障手術、緑内障手術、網膜硝子体手術などの手術において大きな意味を持っています。世界保健機関（WHO）の2022年の統計によると、少なくとも22億人が近視または遠視の障害を持っています。世界的に、このうち少なくとも10億人（ほぼ半数）は、視力障害を予防できたか、まだ対処できていません。視力障害や失明の主な原因は、矯正されていない白内障です。そのため、眼科疾患の患者や手術の急増が、世界の眼科用粘弾性デバイス（OVD）市場の成長に寄与しています。

加えて、新技術の進歩も大きなピークを迎えています。例えば2022年4月、Bausch + Lomb、米国食品医薬品局（FDA）が眼科手術に使用するClearVisc（TM）分散型眼科用粘弾性デバイス（OVD）を承認したと発表しました。このデバイスは、眼科手術中に角膜を保護する卓越した効果を発揮します。眼科用粘弾性デバイス（OVD）の分野におけるこのような技術の進歩は、世界の眼科用粘弾性デバイス（OVD）市場を押し上げる可能性が高いです。

さらに、World Population Prospects（2019）によると、2019年の世界の65歳以上の高齢者は7億300万人でした。さらに、近年の調査、Global Population Aging 2020 Report（国連、2020）によると、老年人口は憂慮すべきペースで増加傾向にあります。2020年、世界には65歳以上の高齢者が約7億2,700万人いました。2050年までに、このような患者の数は倍増し、15億人に達すると予測されています。したがって、老年人口が増加するにつれて、高齢者の目に白内障が発生する可能性が高まり、ひいては世界の眼科用粘弾性デバイス（OVD）市場の成長を後押しします。

上記の要因とともに、眼科用粘弾性デバイス（OVD）市場は、COVID-19の蔓延を抑制するために必要な措置としてロックダウンが課されたため、一時的に後退した時期がありました。この間の主な措置の1つは、多数の選択的手術と外来受診の停止でした。このため、さまざまな診療科にわたる多数の手術がロックダウン初期に中断されたため、市場における眼科用粘弾性デバイス（OVD）の需要が減少し、それによって市場の成長が短期間制限されました。とはいえ、眼科用粘弾性デバイス（OVD）市場は、世界中で多数のCOVID-19ワクチンが承認および投与されたことにより、医療サービスを含むさまざまな領域で活動が再開され、回復期にあります。

眼科用粘弾性デバイス（OVD）市場のセグメント分析

眼科用粘弾性デバイス（OVD）市場のタイプセグメントでは、複合眼科用粘弾性市場セグメントが世界の眼科用粘弾性デバイス（OVD）市場で大きなシェアを占める見込みです。この製品セグメントの市場シェアが大きいのは、これらのデバイスを採用する患者が増加しているためです。

眼科用粘弾性は、分散性と凝集性を併せ持つことがあります。手術中、角膜内皮を保護することは分散的な特性であり、一方、被膜剥離時に水晶体前嚢を平らにすることは凝集的な特性です。多くの外科医にとって、複合眼科用粘弾性の使用は、これらが手術全体の専用粘弾性として使用できることから、両方の長所を兼ね備えています。このような薬剤の例としては、DiscoVisc（Alcon）やAmvisc Plus（B&L）などがあり、いずれも日常的な症例に適したシングルシリンジ薬剤を目指しています。

当レポートでは、世界の眼科用粘弾性デバイス（OVD）市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 眼科用粘弾性デバイス（OVD）市場レポートのイントロダクション

第2章 眼科用粘弾性デバイス（OVD）市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 眼科用粘弾性デバイス（OVD）市場の主な要因の分析

  • 眼科用粘弾性デバイス（OVD）市場の促進要因
    • 眼科疾患の有病率の上昇
    • 老年人口の急増
    • 技術の進歩
  • 眼科用粘弾性デバイス（OVD）の制約と課題
    • 手術後のOVDの除去に伴うリスク
    • 術後合併症
  • 眼科用粘弾性デバイス（OVD）の機会
    • 先進のデバイスに対する選好の高まり
    • 新興国における成長機会

第5章 眼科用粘弾性デバイス（OVD）のポーターのファイブフォース分析

第6章 眼科用粘弾性デバイス（OVD）市場に対するCOVID-19の影響の分析

第7章 眼科用粘弾性デバイス（OVD）市場レイアウト

  • タイプ別
    • 凝集性眼科用粘弾性
    • 分散性眼科用粘弾性
    • 複合眼科用粘弾性
    • 粘度適応性眼科用粘弾性
  • 用途別
    • 白内障手術
    • 緑内障手術
    • 角膜移植
    • 網膜硝子体手術
  • エンドユーザー別
    • 病院
    • 眼科クリニック
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 眼科用粘弾性デバイス（OVD）：世界の企業シェア分析 - 主要3～5社

第9章 眼科用粘弾性デバイス（OVD）の企業と製品のプロファイル

  • Bausch Health Companies Inc.
  • Eyekon Medical Inc.
  • Bohus BioTech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Alcon Inc.
  • Rumex International Corporation
  • Altacor
  • Ophtechnics Unlimited
  • Beaver Visitec Limited
  • PhysIOL
  • Neu Micromed International Pvt. Ltd.
  • Rayner Intraocular Lenses Limited
  • Aurolab
  • Abbott Medical Optics
  • Maxigen Biotech Inc.
  • Amring Pharmaceuticals Inc.
  • Sight Sciences, Inc.
  • Anika Therapeutics, Inc.

第10章 プロジェクトのアプローチ

  • 二次資料
  • 一次資料
  • データの三角測量
  • 主な専門家の意見

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Ophthalmic Viscoelastic Devices Market
  • Table 3 Ophthalmic Viscoelastic Devices Market Analysis in Global (2021-2030)
  • Table 4 Ophthalmic Viscoelastic Devices Market Analysis in Global by Type (2021-2030)
  • Table 5 Ophthalmic Viscoelastic Devices Market Analysis in Global by Application (2021-2030)
  • Table 6 Ophthalmic Viscoelastic Devices Market Analysis in Global by End User (2021-2030)
  • Table 7 Ophthalmic Viscoelastic Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8 Ophthalmic Viscoelastic Devices Market Analysis in North America (2021-2030)
  • Table 9 Ophthalmic Viscoelastic Devices Market Analysis in North America by Type (2021-2030)
  • Table 10 Ophthalmic Viscoelastic Devices Market Analysis in North America by Application (2021-2030)
  • Table 11 Ophthalmic Viscoelastic Devices Market Analysis in North America by End User (2021-2030)
  • Table 12 Ophthalmic Viscoelastic Devices Market Analysis in North America by Country (2021-2030)
  • Table 13 Ophthalmic Viscoelastic Devices Market Analysis in the US (2021-2030)
  • Table 14 Ophthalmic Viscoelastic Devices Market Analysis in Canada (2021-2030)
  • Table 15 Ophthalmic Viscoelastic Devices Market Analysis in Mexico (2021-2030)
  • Table 16 Ophthalmic Viscoelastic Devices Market Analysis in Europe (2021-2030)
  • Table 17 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Type (2021-2030)
  • Table 18 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Application (2021-2030)
  • Table 19 Ophthalmic Viscoelastic Devices Market Analysis in Europe by End User (2021-2030)
  • Table 20 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Country (2021-2030)
  • Table 21 Ophthalmic Viscoelastic Devices Market Analysis in France (2021-2030)
  • Table 22 Ophthalmic Viscoelastic Devices Market Analysis in Germany (2021-2030)
  • Table 23 Ophthalmic Viscoelastic Devices Market Analysis in UK (2021-2030)
  • Table 24 Ophthalmic Viscoelastic Devices Market Analysis in Italy (2021-2030)
  • Table 25 Ophthalmic Viscoelastic Devices Market Analysis in Spain (2021-2030)
  • Table 26 Ophthalmic Viscoelastic Devices Market Analysis in Russia (2021-2030)
  • Table 27 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific (2021-2030)
  • Table 29 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Type (2021-2030)
  • Table 30 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Application (2021-2030)
  • Table 31 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by End User (2021-2030)
  • Table 32 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Country (2021-2030)
  • Table 33 Ophthalmic Viscoelastic Devices Market Analysis in China (2021-2030)
  • Table 34 Ophthalmic Viscoelastic Devices Market Analysis in Japan (2021-2030)
  • Table 35 Ophthalmic Viscoelastic Devices Market Analysis in India (2021-2030)
  • Table 36 Ophthalmic Viscoelastic Devices Market Analysis in Australia (2021-2030)
  • Table 37 Ophthalmic Viscoelastic Devices Market Analysis in South Korea (2021-2030)
  • Table 38 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Asia Pacific (2021-2030)
  • Table 39 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World (2021-2030)
  • Table 40 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Type (2021-2030)
  • Table 41 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Application (2021-2030)
  • Table 42 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by End User (2021-2030)
  • Table 43 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Country (2021-2030)
  • Table 44 Ophthalmic Viscoelastic Devices Market Analysis in Middle East (2021-2030)
  • Table 45 Ophthalmic Viscoelastic Devices Market Analysis in Africa (2021-2030)
  • Table 46 Ophthalmic Viscoelastic Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Ophthalmic Viscoelastic Devices Market
  • Figure 3 Ophthalmic Viscoelastic Devices Market Analysis in Global (2021-2030)
  • Figure 4 Ophthalmic Viscoelastic Devices Market Analysis in Global by Type (2021-2030)
  • Figure 5 Ophthalmic Viscoelastic Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6 Ophthalmic Viscoelastic Devices Market Analysis in Global by End User (2021-2030)
  • Figure 7 Ophthalmic Viscoelastic Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Ophthalmic Viscoelastic Devices Market Analysis in North America (2021-2030)
  • Figure 9 Ophthalmic Viscoelastic Devices Market Analysis in North America by Type (2021-2030)
  • Figure 10 Ophthalmic Viscoelastic Devices Market Analysis in North America by Application (2021-2030)
  • Figure 11 Ophthalmic Viscoelastic Devices Market Analysis in North America by End User (2021-2030)
  • Figure 12 Ophthalmic Viscoelastic Devices Market Analysis in North America by Country (2021-2030)
  • Figure 13 Ophthalmic Viscoelastic Devices Market Analysis in the US (2021-2030)
  • Figure 14 Ophthalmic Viscoelastic Devices Market Analysis in Canada (2021-2030)
  • Figure 15 Ophthalmic Viscoelastic Devices Market Analysis in Mexico (2021-2030)
  • Figure 16 Ophthalmic Viscoelastic Devices Market Analysis in Europe (2021-2030)
  • Figure 17 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Type (2021-2030)
  • Figure 18 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Application (2021-2030)
  • Figure 19 Ophthalmic Viscoelastic Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Ophthalmic Viscoelastic Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Ophthalmic Viscoelastic Devices Market Analysis in France (2021-2030)
  • Figure 22 Ophthalmic Viscoelastic Devices Market Analysis in Germany (2021-2030)
  • Figure 23 Ophthalmic Viscoelastic Devices Market Analysis in UK (2021-2030)
  • Figure 24 Ophthalmic Viscoelastic Devices Market Analysis in Italy (2021-2030)
  • Figure 25 Ophthalmic Viscoelastic Devices Market Analysis in Spain (2021-2030)
  • Figure 26 Ophthalmic Viscoelastic Devices Market Analysis in Russia (2021-2030)
  • Figure 27 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific (2021-2030)
  • Figure 29 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Type (2021-2030)
  • Figure 30 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Application (2021-2030)
  • Figure 31 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by End User (2021-2030)
  • Figure 32 Ophthalmic Viscoelastic Devices Market Analysis in Asia Pacific by Country (2021-2030)
  • Figure 33 Ophthalmic Viscoelastic Devices Market Analysis in China (2021-2030)
  • Figure 34 Ophthalmic Viscoelastic Devices Market Analysis in Japan (2021-2030)
  • Figure 35 Ophthalmic Viscoelastic Devices Market Analysis in India (2021-2030)
  • Figure 36 Ophthalmic Viscoelastic Devices Market Analysis in Australia (2021-2030)
  • Figure 37 Ophthalmic Viscoelastic Devices Market Analysis in South Korea (2021-2030)
  • Figure 38 Ophthalmic Viscoelastic Devices Market Analysis in Rest of Asia Pacific (2021-2030)
  • Figure 39 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World (2021-2030)
  • Figure 40 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Type (2021-2030)
  • Figure 41 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Application (2021-2030)
  • Figure 42 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by End User (2021-2030)
  • Figure 43 Ophthalmic Viscoelastic Devices Market Analysis in Rest of the World by Country (2021-2030)
  • Figure 44 Ophthalmic Viscoelastic Devices Market Analysis in Middle East (2021-2030)
  • Figure 45 Ophthalmic Viscoelastic Devices Market Analysis in Africa (2021-2030)
  • Figure 46 Ophthalmic Viscoelastic Devices Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0134

Ophthalmic Viscoelastic Devices Market By Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, Visco-Adaptive Ophthalmic Viscoelastic), By Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, Others), And By End-User (Hospitals, Ophthalmology Clinics, Others), by geography, is expected to grow at a steady CAGR forecast till 2030 owing to the technological advancements and surge in the geriatric population

Global Ophthalmic Viscoelastic Devices Market was valued at USD 2.50 billion in 2023, growing at a CAGR of 4.23% during the forecast period from 2024 to 2030, to reach USD 3.21 billion by 2030. The Ophthalmic Viscoelastic Devices market is expected to witness growth due to the rising prevalence of ophthalmic conditions like cataracts, glaucoma, and others, technological advancements, and the surge in the geriatric population.

Ophthalmic Viscoelastic Devices Market Dynamics:

Ophthalmic Viscoelastic Devices (OVDs) Market has significantly increased due to the fact that for many years, Ophthalmic Viscoelastic Devices have been used in intraocular surgery to protect delicate structures inside the eyes. The use of these devices has major significance during procedures like cataract surgeries, glaucoma surgeries, vitreoretinal surgeries. As per World Health Organization 2022, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion - or almost half - of these cases, vision impairment could have been prevented or has yet to be addressed globally. The leading causes of vision impairment and blindness are uncorrected cataracts. Thus, the burgeoning cases of ophthalmic conditions and surgeries will contribute to the Global Ophthalmic Viscoelastic Devices Market growth.

In addition, the advancement of new technologies is advancing at a great peak. For instance, in April 2022, Bausch + Lomb announced that the US Food and Drug Administration (FDA) approved ClearVisc(TM) dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. The device offers exceptional corneal protection during ophthalmic surgery. Such technological advancement in the field of Ophthalmic Viscoelastic Devices is likely to boost the Global Ophthalmic Viscoelastic Devices Market.

Furthermore, as per the World Population Prospects, 2019, there were 703 million older persons aged 65 or over in 2019 globally. Moreover, as per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure for such patients is expected to double and reach 1.5 billion by 2050. Therefore, as the aging population increases, there will be more chances of the older population getting cataracts in their eyes, which will eventually boost the growth of the Global Ophthalmic Viscoelastic Devices market.

Along with the above-mentioned factors, the Ophthalmic Viscoelastic Devices market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Ophthalmic Viscoelastic Devices in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for Ophthalmic Viscoelastic Devices is in the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Ophthalmic Viscoelastic Devices market during the forecast period.

Ophthalmic Viscoelastic Devices Market Segment Analysis:

Ophthalmic Viscoelastic Devices Market By Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, Visco-Adaptive Ophthalmic Viscoelastic), by Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, Others), Ophthalmic Viscoelastic Devices Market by End-User (Hospitals, Ophthalmology Clinics, Others), and Ophthalmic Viscoelastic Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Ophthalmic Viscoelastic Devices market tye segment, the Combination Ophthalmic Viscoelastic market segment will hold the major share of the Global Ophthalmic Viscoelastic Devices market. The large market share of this product segment can be attributed to the growing patient adoption of these devices.

Combination Ophthalmic Viscoelastic may have some dispersive properties as well as some cohesive properties. Protecting the corneal endothelium throughout the surgery is a dispersive characteristic while flattening the anterior lens capsule during capsulorhexis is a cohesive attribute. For many surgeons, using a Combination of Ophthalmic Viscoelastic has the best of both as they can use it as the exclusive viscoelastic for the entire surgery. Examples of these agents include DiscoVisc (Alcon) and Amvisc Plus (B&L), both of which aim to be good single-syringe agents for routine cases.

Realizing that two separate OVDs offer more versatility than a single agent, companies offer dual-viscoelastic systems, which incorporate a dispersive OVD and a cohesive OVD in separate syringes which are known as Dual OVD Packages. These can be opened together, though they are not packaged as such.

Therefore, Combination Ophthalmic Viscoelastic Devices are gaining commercial acceptability, which improves market penetration. All these advantages of these devices make physicians more inclined to use Combination Ophthalmic Viscoelastic.

Hence, all the above-mentioned factors are expected to drive the segment growth of the Ophthalmic Viscoelastic Devices market.

North America is expected to dominate the overall Global Ophthalmic Viscoelastic Devices Market:

North America is expected to dominate the overall Ophthalmic Viscoelastic Devices market during the forecast period. This domination is due to the rising number of cataract surgeries, and other ophthalmic surgeries in the region. As per the Journal of Cataract Refract Surgeries 2020, the volume of cataract surgeries performed per year has increased steadily over the past few decades in the United States.

Additionally, according to Cancer Vision 2020, based on the trends in the surgical volume of cataract surgery over the past decade, 3.7 million cataract cases would have been performed in 2020 in the United States among Medicare beneficiaries. Thus, the burgeoning cases of cataract surgeries will contribute to the growth of the Ophthalmic Viscoelastic Devices Market in the region as the demand will increase.

Further, in North America, the market is supported by developed healthcare infrastructure and strong adoption of technologically advanced products owing to the rise in healthcare expenditure by the government and increase prevalence and incidence of surgeries as mentioned above.

Europe and Asia-Pacific region have the future potential growth for the Global Ophthalmic Viscoelastic Devices market. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Ophthalmic Viscoelastic Devices market. For instance, in May 2020 BVI announced the acquisition of the ophthalmic viscoelastic device (OVD) assets from Croma, an Austrian-based company. In addition to the acquisition of existing products, BVI and Croma have embarked on an R&D collaboration on additional products that will come to market in the future. Such initiatives are anticipated to boost the Ophthalmic Viscoelastic Devices Market.

Ophthalmic Viscoelastic Devices Market Key Players:

Some of the key market players operating in the Global Ophthalmic Viscoelastic Devices Market include Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc., Anika Therapeutics, Inc. among others.

Recent Developmental Activities in the Ophthalmic Viscoelastic Devices Market:

In June 2022, Rayner announced that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. This acquisition helped Rayner to rapidly bring its strong pipeline of innovative intraocular lenses (IOLs), ophthalmic viscoelastic devices (OVDs), and dry eye drop solutions to surgeons and patients across India, and further develop its global presence.

In April 2022, Bausch + Lomb announced that the FDA has approved its ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.

Key Takeaways from the Ophthalmic Viscoelastic Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Ophthalmic Viscoelastic Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Ophthalmic Viscoelastic Devices Market.

Various opportunities are available for the other competitor in the Ophthalmic Viscoelastic Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Ophthalmic Viscoelastic Devices market growth in the coming future?

Target Audience who can be benefited from this Ophthalmic Viscoelastic Devices Market Ket Report Study

Ophthalmic Viscoelastic Devices providers

Research organizations and consulting companies

Ophthalmic Viscoelastic Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Ophthalmic Viscoelastic Devices

Various End-users want to know more about the Ophthalmic Viscoelastic Devices Market and the latest technological developments in the Ophthalmic Viscoelastic Devices market.

Frequently Asked Questions for Ophthalmic Viscoelastic Devices Market:

1. What are Ophthalmic Viscoelastic Devices?

Ophthalmologists use ophthalmic viscoelastic devices (OVDs) in multiple eye operations, such as cataract surgery, glaucoma surgery, among others. These devices help secure the fragile eye structures along with creating pressure in the anterior cavity, compartmentalizing the interior of the eye, and providing patients with faster healing for easier and safer surgery.

2. What is the market for Global Ophthalmic Viscoelastic Devices?

Global Ophthalmic Viscoelastic Devices Market was valued at USD 2.50 billion in 2023, growing at a CAGR of 4.23% during the forecast period from 2024 to 2030, to reach USD 3.21 billion by 2030.

3. What are the drivers for Global Ophthalmic Viscoelastic Devices?

The major drivers driving the demand for Ophthalmic Viscoelastic Devices are the growth due to the rising prevalence of ophthalmic conditions like cataracts, glaucoma, and others, technological advancements, and the surge in the geriatric population.

4. What are the key players operating in Global Ophthalmic Viscoelastic Devices?

Some of the key market players operating in the Ophthalmic Viscoelastic Devices market include Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc. Anika Therapeutics, Inc., and others.

5. What regions have the highest share in the Ophthalmic Viscoelastic Devices market?

North America is expected to dominate the overall global Ophthalmic Viscoelastic Devices market during the forecast period from 2024 to 2030. This domination is due to the rising number of cataract surgeries, and other ophthalmic surgeries in the region.

Table of Contents

1.Ophthalmic Viscoelastic Devices Market Report Introduction

2.Ophthalmic Viscoelastic Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Ophthalmic Viscoelastic Devices Market Key factors analysis

  • 4.1 Ophthalmic Viscoelastic Devices Market Drivers
    • 4.1.1 Rising prevalence of ophthalmic conditions
    • 4.1.2 The surge in geriatric population
    • 4.1.3 Rising technological advancements
  • 4.2 Ophthalmic Viscoelastic Devices Restraints and Challenges
    • 4.2.1 The risk associated with removal of OVDs after surgery
    • 4.2.2 Postoperative complications
  • 4.3 Ophthalmic Viscoelastic Devices Opportunities
    • 4.3.1 Growing preference for advanced devices
    • 4.3.2 Growth opportunities in emerging countries

5. Ophthalmic Viscoelastic Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Ophthalmic Viscoelastic Devices Market

7. Ophthalmic Viscoelastic Devices Market layout

  • 7.1 By Type
    • 7.1.1 Cohesive Ophthalmic Viscoelastic
    • 7.1.2 Dispersive Ophthalmic Viscoelastic
    • 7.1.3 Combination Ophthalmic Viscoelastic
    • 7.1.4 Visco-Adaptive Ophthalmic Viscoelastic
  • 7.2 By Application
    • 7.2.1 Cataract Surgery
    • 7.2.2 Glaucoma Surgery
    • 7.2.3 Corneal Transplantation
    • 7.2.4 Vitreoretinal Surgery
  • 7.3 By End User
    • 7.3.1 Hospitals
    • 7.3.2 Ophthalmology Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.1.2 North America Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.1.3 North America Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.1.4 North America Ophthalmic Viscoelastic Devices Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.2.2 Europe Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.2.3 Europe Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.2.4 Europe Ophthalmic Viscoelastic Devices Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.3.2 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.3.3 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.3.4 Asia-Pacific Ophthalmic Viscoelastic Devices Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Ophthalmic Viscoelastic Devices Market, by Type
      • 7.4.4.2 RoW Ophthalmic Viscoelastic Devices Market, by Application
      • 7.4.4.3 RoW Ophthalmic Viscoelastic Devices Market, by End User
      • 7.4.4.4 RoW Ophthalmic Viscoelastic Devices Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Ophthalmic Viscoelastic Devices Global Company Share Analysis - Key 3-5 Companies

9. Ophthalmic Viscoelastic Devices Company and Product Profiles

  • 9.1 Bausch Health Companies Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Eyekon Medical Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Bohus BioTech AB
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Carl Zeiss Meditec AG
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 CIMA Technology Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Johnson & Johnson Vision Care, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Alcon Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Rumex International Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Altacor
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Ophtechnics Unlimited
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Beaver Visitec Limited
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 PhysIOL
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Neu Micromed International Pvt. Ltd.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Rayner Intraocular Lenses Limited
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Aurolab
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Abbott Medical Optics
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Maxigen Biotech Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Amring Pharmaceuticals Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Sight Sciences, Inc.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy Anika Therapeutics, Inc.
  • 9.20 Anika Therapeutics, Inc.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. PROJECT APPROACH

  • 10.1 Secondary Sources
  • 10.2 Primary Sources
  • 10.3 Data Triangulation
  • 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight